tiprankstipranks
Advertisement
Advertisement

GRCE Stock Latest News

Midday Fly By: Trump says Apple working with Intel to design chips
The FlyMidday Fly By: Trump says Apple working with Intel to design chips
15d ago
KR
ACN
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
PremiumCompany Announcements
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
16d ago
8K
GRCE
Grace Therapeutics reports FY26 EPS (47c) vs (79c) last year
PremiumThe Fly
Grace Therapeutics reports FY26 EPS (47c) vs (79c) last year
16d ago
GRCE
Grace Therapeutics VP of Clinical Operations Departs Role
PremiumCompany Announcements
Grace Therapeutics VP of Clinical Operations Departs Role
28d ago
8K
GRCE
Largest borrow rate increases among liquid names
PremiumThe Fly
Largest borrow rate increases among liquid names
2M ago
PS
KDK
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
2M ago
BUD
KDK
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
Premium
Company Announcements
Grace Therapeutics Updates GTx-104 Regulatory and Trial Progress
2M ago
8K
GRCE
Grace Therapeutics price target lowered to $4 from $11 at Craig-Hallum
Premium
The Fly
Grace Therapeutics price target lowered to $4 from $11 at Craig-Hallum
2M ago
GRCE
Grace Therapeutics price target lowered to $8 from $12 at TD Cowen
PremiumThe Fly
Grace Therapeutics price target lowered to $8 from $12 at TD Cowen
2M ago
GRCE
Grace Therapeutics: Buy Rating Maintained as Addressable CMC Setback Delays but Does Not Derail GTx‑104 Value Thesis
PremiumRatings
Grace Therapeutics: Buy Rating Maintained as Addressable CMC Setback Delays but Does Not Derail GTx‑104 Value Thesis
2M ago
GRCE
Grace Therapeutics Receives FDA Complete Response for GTx-104
PremiumCompany Announcements
Grace Therapeutics Receives FDA Complete Response for GTx-104
2M ago
8K
GRCE
Grace Therapeutics down 48% after receipt of CRL from FDA for GTx-104
PremiumThe Fly
Grace Therapeutics down 48% after receipt of CRL from FDA for GTx-104
2M ago
GRCE
Grace Therapeutics, Inc trading resumes
PremiumThe FlyGrace Therapeutics, Inc trading resumes
2M ago
GRCE
Grace Therapeutics issued Complete Response Letter from FDA
Premium
The Fly
Grace Therapeutics issued Complete Response Letter from FDA
2M ago
GRCE
Grace Therapeutics, Inc trading halted, news pending
Premium
The Fly
Grace Therapeutics, Inc trading halted, news pending
2M ago
GRCE
Grace Therapeutics reports Q3 EPS (14c) vs (36c) last year
PremiumThe Fly
Grace Therapeutics reports Q3 EPS (14c) vs (36c) last year
5M ago
GRCE
Ten new option listings and two option delistings on January 22nd
PremiumThe Fly
Ten new option listings and two option delistings on January 22nd
5M ago
AVR
INR
Grace Therapeutics Enhances Executive Severance and Change‑in‑Control Terms
PremiumCompany Announcements
Grace Therapeutics Enhances Executive Severance and Change‑in‑Control Terms
6M ago
8K
GRCE
Grace Therapeutics Reports Q2 2026 Results and FDA Progress
PremiumCompany Announcements
Grace Therapeutics Reports Q2 2026 Results and FDA Progress
8M ago
GRCE
Grace Therapeutics Announces Q2 2026 Financial Results
PremiumCompany AnnouncementsGrace Therapeutics Announces Q2 2026 Financial Results
8M ago
8K
GRCE
Grace Therapeutics reports Q2 EPS (6c) vs (30c) last year
Premium
The Fly
Grace Therapeutics reports Q2 EPS (6c) vs (30c) last year
8M ago
GRCE
Grace Therapeutics Secures $4M Through Warrant Exercise
Premium
Company Announcements
Grace Therapeutics Secures $4M Through Warrant Exercise
8M ago
8K
GRCE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >